EKF Diagnostics Holdings Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
EKF Diagnostics Holdings Stock Forecast and Price Target
According to experts, who recently provided their 2024 price targets for EKF Diagnostics Holdings, the average price target is £0.35, with a high estimate of £0.36 and a low estimate of £0.29. That is a potential upside of approximately 20.69% from the last closing price of £0.29 on April, 2024. If you're looking for EKF Diagnostics Holdings (EKF) stock information, you might also want to check out Procter & Gamble (NYSE:PG).
20.69% Upside
EKF Diagnostics Holdings Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, EKF Diagnostics Holdings's Price has fallen from £0.56 to £0.00 – a 100.00% decrease. For next year, analysts predict Fair Value of £0.28, which would mean an increase of 100.00%. Over the next seven years, experts predict that EKF Diagnostics Holdings's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PG Stock Forecast | Procter & Gamble | Outperform |
12
|
$163.20 | Buy/Sell | $166.80 | 6.62% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$105.97 | Buy/Sell | $118.92 | 19.37% |
| CHD Stock Forecast | Church & Dwight Co Inc | Hold |
11
|
$107.89 | Buy/Sell | $96.90 | -2.03% |
| BIM Stock Forecast | bioMérieux | Outperform |
18
|
100.00€ | Buy/Sell | 105.55€ | 14.00% |
| BIO Stock Forecast | Bio-Rad Laboratories Inc | Buy |
16
|
$269.75 | Buy/Sell | $536.80 | 58.18% |
EKF Diagnostics Holdings Revenue Forecast for 2023 - 2025 - 2030
In the last two years, EKF Diagnostics Holdings's Revenue has grown by 2.11%, rising from £65.26M to £66.64M. For next year, analysts predict Revenue of £72.27M, which would mean an increase of 8.45%. Over the next eight years, experts predict that EKF Diagnostics Holdings's Revenue will grow at a rate of 9.05%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| QDEL Stock Forecast | Quidel Corp | Hold |
16
|
$40.55 | Buy/Sell | $121.00 | 31.20% |
| ALBIO Stock Forecast | Biosynex | - |
16
|
6.28€ | Buy/Sell | 0.00€ | -100.00% |
| AT1 Stock Forecast | Atomo Diagnostics | - |
0
|
$0.03 | Buy/Sell | $0.11 | -100.00% |
.jpg)
EKF Diagnostics Holdings Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, EKF Diagnostics Holdings's Dividend per Share has decreased from £0.01 to £0.01 – a 0.00% drop. In the following year, 4 experts forecast that EKF Diagnostics Holdings's Dividend per Share will decrease by 0.00%, to £0.01. For the next seven years, the forecast is for Dividend per Share to grow by 58.28%.
EKF Diagnostics Holdings EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, EKF Diagnostics Holdings's EBITDA has decreased from £19.49M to £13.16M – a 32.48% drop. For the following year, the 4 analysts predict that EKF Diagnostics Holdings's EBITDA will drop by 11.85%, reaching £11.60M. For the next seven years, the forecast is for EBITDA to grow by 48.94%.
EKF Diagnostics Holdings EBIT Forecast for 2023 - 2025 - 2030
EKF Diagnostics Holdings's EBIT has decreased by 45.23% In the last two years, from £15.61M to £8.55M. In the following year, the 3 analysts surveyed believe that EKF Diagnostics Holdings's EBIT will decrease by 31.93%, reaching £5.82M. According to professionals, by 2030, EKF Diagnostics Holdings's EBIT will have decreased by 2.85%, falling down to £8.31M.
EKF Diagnostics Holdings EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, EKF Diagnostics Holdings's EPS has fallen from £0.02 to £0.00 – a 100.00% decrease. For next year, analysts predict EPS of £0.01, which would mean an increase of 100.00%. Over the next seven years, experts predict that EKF Diagnostics Holdings's EPS will grow at a rate of 100.00%.
Site Navigation
.jpg)